Regulation of osteogenesis by fetuin

被引:109
作者
Binkert, C
Demetriou, M
Sukhu, B
Szweras, M
Tenenbaum, HC
Dennis, JW
机构
[1] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Mt Sinai Hosp, Dept Dent, Toronto, ON M5G 1X5, Canada
[3] Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X5, Canada
[4] Univ Toronto, Dept Med, Toronto, ON M5G 1X5, Canada
关键词
D O I
10.1074/jbc.274.40.28514
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Osteoporosis is a common problem of aging and results from a failure of homeostatic mechanisms to regulate osteogenesis and mineralization, Bovine and human forms of fetuin glycoprotein bind to the transforming growth factor (TGF)-beta/BMP (bone morphogenic protein) cytokines and block their osteogenic activity in cell culture assays (Demetriou, M., Binkert, C,, Sukhu, B., Tenenbaum, H. C., and Dennis, J. W. (1996) J, Biol. Chem, 271, 12755-12761). Fetuin is a prominent serum glycoprotein and a major noncollagenous component of mineralized bone in mammals. In this study, we show that recombinant fetuin and native serum protein have similar potency as inhibitors of osteogenesis in dexamethasone-treated rat bone marrow cell cultures (dex-RBMC). Recombinant bovine fetuin also bound to TGF-beta 1 and BMP-2 in vitro with kinetics similar to native fetuin, Although TGF-beta 1 is required for osteogenesis in dex-RBMC, the cytokine also inhibited osteogenesis at concentrations greater than or equal to 10 pM. Titration of fetuin or anti-TGF-beta 1 antibodies into the bone marrow cultures in the presence of 10 pM TGF-beta 1 restored osteogenesis, whereas titrations of the same reagents into cultures with 0.3 pM added TGF-beta 1 were inhibitory, confirming the biphasic nature of the TGF-beta 1 response. Suppression of osteogenesis by both TGF-beta 1 and the antagonist proteins required their presence within the first 6 days of culture, well before mineralization at 10-12 days. Northern analysis showed that both fetuin and high dose TGF-beta 1 suppressed expression of the bone-associated transcripts alkaline phosphatase, osteopontin, collagen type I, and bone sialoprotein. The suppression of osteogenesis by fetuin and by high dose TGF-beta 1 was accompanied by the differentiation of an alternate cell lineage with adipocyte characteristics. In summary, the biphasic osteogenic response to TGF-beta 1 suggests that overlapping gradients of TGF-beta/EMP cytokines and fetuin regulate osteogenesis in remodeling bone.
引用
收藏
页码:28514 / 28520
页数:7
相关论文
共 42 条
[1]   PLASMA ALPHA-2-HS-GLYCOPROTEIN CONCENTRATION IN PAGETS-DISEASE OF BONE - ITS POSSIBLE SIGNIFICANCE [J].
ASHTON, BA ;
SMITH, R .
CLINICAL SCIENCE, 1980, 58 (05) :435-438
[2]   Protease helps yeast find mating partners [J].
Barkai, N ;
Rose, MD ;
Wingreen, NS .
NATURE, 1998, 396 (6710) :422-423
[3]  
BASKIES AM, 1980, CANCER, V45, P3050, DOI 10.1002/1097-0142(19800615)45:12<3050::AID-CNCR2820451229>3.0.CO
[4]  
2-8
[5]   Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6 [J].
Boden, SD ;
Hair, G ;
Titus, L ;
Racine, M ;
McCuaig, K ;
Wozney, JM ;
Nanes, MS .
ENDOCRINOLOGY, 1997, 138 (07) :2820-2828
[6]   Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton [J].
Brunet, LJ ;
McMahon, JA ;
McMahon, AP ;
Harland, RM .
SCIENCE, 1998, 280 (5368) :1455-1457
[7]   TRANSFORMING GROWTH-FACTOR-BETA AND REMODELING OF BONE [J].
CENTRELLA, M ;
MCCARTHY, TL ;
CANALIS, E .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1991, 73A (09) :1418-1428
[8]  
CENTRELLA M, 1995, MOL CELL BIOL, V15, P3273
[9]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[10]   Fetuin/alpha 2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist [J].
Demetriou, M ;
Binkert, C ;
Sukhu, B ;
Tenenbaum, HC ;
Dennis, JW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :12755-12761